Impedimed Ltd has released a press release.
PREVENT Trial accepted for Publication and Presentation
Filed with ASX ·
Watch Impedimed's latest callImpedimed (ASX:IPD) Q1 2027 Earnings Call · Replay · Oct 29Read the transcript of Impedimed (ASX:IPD) Q1 2027 Earnings Call6ix hasn’t read this filing yet.
Story so far
Earlier from Impedimed
- Ascension National Purchasing Agreement Received
- Appendix 4C - Quarter ended 30 September 2018
- ImpediMed Completes Asset Sale of XiTRON Technologies, Inc.
- S&P DJI Announces September 2018 Quarterly Rebalance
- Response to ASX Aware Query
Later from Impedimed
- Appendix 4C - Quarter ended 31 December 2018
- S&P DJI Announces March 2019 Quarterly Rebalance
- US Investor Presentation
- Appendix 4C - Quarter ended 31 March 2019
- ASBrS Releases PREVENT Abstract
Follow Impedimed into a list and get an email when it puts out news.
Follow Impedimed